Resultados de procura - Neeta Pandit‐Taskar

Limitar resultados
  1. 1
    Norepinephrine Transporter as a Target for Imaging and Therapy

    Norepinephrine Transporter as a Target for Imaging and Therapy por Neeta Pandit‐Taskar, Shakeel Modak

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer por Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with <sup>223</sup>Ra-Dichloride

    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with <sup>223</sup>Ra-Dichloride por Neeta Pandit‐Taskar, Steven M. Larson, Jorge A. Carrasquillo

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates

    Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates por Brian Quinn, Z. L. Dauer, Neeta Pandit‐Taskar, Heiko Schöder, Lawrence T. Dauer

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Molecular Imaging of Biomarkers in Breast Cancer

    Molecular Imaging of Biomarkers in Breast Cancer por Gary A. Ulaner, Christopher C. Riedl, Maura N. Dickler, Komal Jhaveri, Neeta Pandit‐Taskar, Wolfgang Weber

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Patient-specific organ and effective dose estimates in pediatric oncology computed tomography

    Patient-specific organ and effective dose estimates in pediatric oncology computed tomography por Yiming Gao, Brian Quinn, Neeta Pandit‐Taskar, Gerald Behr, Usman Mahmood, D Long, Xiaobin Xu, Jean St. Germain, Lawrence T. Dauer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblasto... por Nai‐Kong V. Cheung, Irene Y. Cheung, Kim Kramer, Shakeel Modak, Deborah Kuk, Neeta Pandit‐Taskar, Elizabeth Chamberlain, Irina Ostrovnaya, Brian H. Kushner

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival

    Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival por Evis Sala, Masako Kataoka, Neeta Pandit‐Taskar, Nicole Ishill, Svetlana Mironov, Chaya S. Moskowitz, Oleg Mironov, Michelle A. Collins, S. Dennis, Steven M. Larson, Hedvig Hricak

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer

    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer por Mary L. Gemignani, Sujata Patil, Venkatraman Seshan, Michelle Sampson, John L. Humm, Jason S. Lewis, Edi Brogi, Steven M. Larson, Monica Morrow, Neeta Pandit‐Taskar

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors por Simone Krebs, Neeta Pandit‐Taskar, Diane Reidy‐Lagunes, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang Weber, Joseph A. O’Donoghue

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma

    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma por John P. Diaz, Mary L. Gemignani, Neeta Pandit‐Taskar, Kay J. Park, Melissa P. Murray, S. Dennis, Yukio Sonoda, Richard R. Barakat, Nadeem R. Abu‐Rustum

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    A comparison of pediatric and adult CT organ dose estimation methods

    A comparison of pediatric and adult CT organ dose estimation methods por Yiming Gao, Brian Quinn, Usman Mahmood, D Long, Yusuf E. Erdi, Jean St. Germain, Neeta Pandit‐Taskar, X. George Xu, Wesley E. Bolch, Lawrence T. Dauer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Impact of pre-operative positron emission tomography in gallbladder cancer

    Impact of pre-operative positron emission tomography in gallbladder cancer por Universe Leung, Neeta Pandit‐Taskar, Carlos U. Corvera, Michael I. D’Angelica, Peter J. Allen, T. Peter Kingham, Ronald P. DeMatteo, William R. Jarnagin, Yuman Fong

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y Radioimmunotherapy

    Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y... por Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Michael J. Morris, Eze A. Wills, Lawrence H. Schwartz, Mithat Gönen, Howard I. Scher, Steven M. Larson, Chaitanya Divgi

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma? por Nadeem R. Abu‐Rustum, Fady Khoury‐Collado, Neeta Pandit‐Taskar, Robert A. Soslow, Fanny Dao, Yukio Sonoda, Douglas A. Levine, Carol L. Brown, S. Dennis, Richard R. Barakat, Mary L. Gemignani

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan por Diane Reidy‐Lagunes, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Simone Krebs, Kevin D. Staton, Serge K. Lyashchenko, Jason S. Lewis, Nitya Raj, Mithat Gönen, Christian Lohrmann, Lisa Bodei, Wolfgang Weber

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy

    Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy por Constantinos T. Sofocleous, Alessandra R. Garcia, Neeta Pandit‐Taskar, Richard Kinh Gian, Lynn A. Brody, Elena N. Petre, Marinela Capanu, Anne P. Longing, Joanne F. Chou, Jorge A. Carrasquillo, Nancy E. Kemeny

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia

    Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia por Todd Rosenblat, Michael R. McDevitt, Deborah Mulford, Neeta Pandit‐Taskar, Chaitanya Divgi, Katherine S. Panageas, Mark Heaney, Suzanne Chanel, Alfred Morgenstern, George Sgouros, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors

    Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors por Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Chaitanya Divgi, Eze A. Wills, Lawrence H. Schwartz, Mithat Gönen, Peter Smith‐Jones, Neil H. Bander, Howard I. Scher, Steven M. Larson, Michael J. Morris

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

    Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer por Christian Lohrmann, Eileen M. O’Reilly, Joseph A. O’Donoghue, Neeta Pandit‐Taskar, Jorge A. Carrasquillo, Serge K. Lyashchenko, Shutian Ruan, Rebecca Teng, Wolfgang Scholz, Paul W. Maffuid, Jason S. Lewis, Wolfgang Weber

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: